Adalta Ltd has released a press release.
AdAlta receives Orphan Designation for AD-114
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from AdAlta
- Positive Pre-clinical Data
- Commercialisation Agreement with Crossbeta Biosciences
- Quarterly Review and Appendix 4C
- Receipt of Innovation Connections Grant
- Agreement with FujiFilm Diosynth Biotechnologies
Later from AdAlta
- AdAlta expands partnership with Alfred Hospital
- Presentation of Eye Fobrosis Data at ARVO Meeting
- Toxicology study and manufacturing update
- AdAlta awarded SIEF grant
- Results of multi-dose toxicology study
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta